Čájehuvvojit 1 - 5 oktiibuot 5 bohtosis ohcui Marieke E. Ijsselsteijn (17142168)', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Supplementary Table S5 from Neoantigen Targetability in Progressive Advanced Melanoma

    Supplementary Table S5 from Neoantigen Targetability in Progressive Advanced Melanoma Dahkki Jitske van den Bulk (17142147)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Supplementary Table S4 from Neoantigen Targetability in Progressive Advanced Melanoma

    Supplementary Table S4 from Neoantigen Targetability in Progressive Advanced Melanoma Dahkki Jitske van den Bulk (17142147)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Supplementary Table S1 from Neoantigen Targetability in Progressive Advanced Melanoma

    Supplementary Table S1 from Neoantigen Targetability in Progressive Advanced Melanoma Dahkki Jitske van den Bulk (17142147)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Supplementary Table S2 from Neoantigen Targetability in Progressive Advanced Melanoma

    Supplementary Table S2 from Neoantigen Targetability in Progressive Advanced Melanoma Dahkki Jitske van den Bulk (17142147)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Supplementary Table S3 from Neoantigen Targetability in Progressive Advanced Melanoma

    Supplementary Table S3 from Neoantigen Targetability in Progressive Advanced Melanoma Dahkki Jitske van den Bulk (17142147)

    Almmustuhtton 2025
    Eará dahkkit:
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: